INtelligent Clinical Systems

About the offering

Intelligent Clinical Systems (ICS) is an early-stage health technology company based in Tucson, AZ, building AI-powered infrastructure for hospital supply management. The company's flagship product, Ambi, is a voice-activated, LED-guided supply retrieval system that mounts directly onto existing supply racks. Clinicians speak the name of an item they need, and Ambi illuminates the correct slot in under one second — with no screens, no apps, no cloud connectivity, and no patient health information (PHI) involved. Ambi runs on DECA (Deterministic Edge Control Architecture), a proprietary on-device system inspired by aerospace and medical-device engineering standards, designed to function even during network or power outages. Installation takes approximately 30 minutes on any existing rack with no IT integration or capital-committee approval required. The problem ICS addresses is that hospital supply rooms remain largely analog despite massive investment in electronic health records. New, float, and agency staff are at particular risk of inefficiency, and even experienced nurses lose time searching for supplies — especially under stress, when clinical recall degrades. ICS argues that supply location is a memory-dependent task that should be offloaded to infrastructure. The business model combines upfront hardware sales with recurring per-rack SaaS fees. A 250-rack hospital deployment is estimated at roughly $1M in hardware revenue and $120K in annual recurring revenue (ARR), with projected customer ROI in under six months based on recovered nurse time. The low per-department cost is designed to allow department-level purchasing decisions rather than capital-committee approval. ICS is pre-revenue with a validated prototype. Key milestones ahead include securing the first written pilot commitment, completing non-provisional patent filings (planned June 2026), and initiating paying pilot deployments. The company has filed 4 provisional patents, received a National Science Foundation Phase I invitation, won the Main Stage and Catalyst Award at the 2026 IdeaFunding Tucson event, and has been selected as a presenter at Venture Madness 2026 and TechConnect World 2026. The company also has an academic collaboration with UCI Samueli School of Engineering and has been nominated for the 2026 Arizona Governor's Innovator of the Year (Startup category). The founding team is led by Robert Schmid, a critical care nurse and cybersecurity engineer. The team also includes a fractional CFO with Fortune 500 and startup experience, a senior technical advisor with NSF CAREER Award recognition, and several additional advisors and engineers. ICS is raising via a SAFE under Regulation CF on Wefunder. Planned use of proceeds: 40% engineering, 25% sales and pilots, 15% operations, 10% G&A, 10% reserve. The company has raised $65,850 from 4 investors to date. Key risks include pre-revenue status, unvalidated clinical performance targets, dependence on pilot-to-contract conversion, patent filing timing, and manufacturing and regulatory execution.

FAQ